These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9229168)

  • 1. Parenteral nutrition-associated cholestasis.
    Teitelbaum DH
    Curr Opin Pediatr; 1997 Jun; 9(3):270-5. PubMed ID: 9229168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of liver biopsy in the evaluation of pediatric total parenteral nutrition cholestasis.
    Buonpane CL; Ares GJ; Englert EG; Helenowski I; Cohran VC; Hunter CJ
    Am J Surg; 2018 Oct; 216(4):672-677. PubMed ID: 30041734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ursodeoxycholic acid therapy for intractable total parenteral nutrition-associated cholestasis in surgical very low birth weight infants.
    Al-Hathlol K; Al-Madani A; Al-Saif S; Abulaimoun B; Al-Tawil K; El-Demerdash A
    Singapore Med J; 2006 Feb; 47(2):147-51. PubMed ID: 16435058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early treatment with ursodeoxycholic acid for cholestasis in children on parenteral nutrition because of primary intestinal failure.
    De Marco G; Sordino D; Bruzzese E; Di Caro S; Mambretti D; Tramontano A; Colombo C; Simoni P; Guarino A
    Aliment Pharmacol Ther; 2006 Jul; 24(2):387-94. PubMed ID: 16842466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New approaches to understanding the etiology and treatment of total parenteral nutrition-associated cholestasis.
    Moss RL; Amii LA
    Semin Pediatr Surg; 1999 Aug; 8(3):140-7. PubMed ID: 10461327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ursodeoxycholic acid treatment in preterm infants: a pilot study for the prevention of cholestasis associated with total parenteral nutrition.
    Arslanoglu S; Moro GE; Tauschel HD; Boehm G
    J Pediatr Gastroenterol Nutr; 2008 Feb; 46(2):228-31. PubMed ID: 18223390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cholestasis associated with prolonged parenteral nutrition in neonates: the role of urso-deoxycholic acid].
    Garzón L; Ledo A; Cubells E; Sáenz P; Vento M
    An Pediatr (Barc); 2009 Jun; 70(6):547-52. PubMed ID: 19443280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathogenesis and progress in treatment of neonatal total parenteral nutrition-associated cholestasis].
    Zhu MZ; Shan RB
    Zhonghua Er Ke Za Zhi; 2008 Jan; 46(1):35-7. PubMed ID: 18353236
    [No Abstract]   [Full Text] [Related]  

  • 9. The biochemical and histopathological effects of ursodeoxycholic acid and metronidazole on total parenteral nutrition-associated hepatic dysfunction: an experimental study.
    Günsar C; Melek M; Karaca I; Sencan A; Mir E; Ortaç R; Canan O
    Hepatogastroenterology; 2002; 49(44):497-500. PubMed ID: 11995481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursodeoxycholic acid for preventing parenteral nutrition-associated cholestasis in neonates: A systematic review and meta-analysis.
    Anne RP; Kadyada SP; Aradhya AS; Oleti TP
    Fundam Clin Pharmacol; 2024 Aug; 38(4):685-694. PubMed ID: 38342497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric parenteral nutrition-associated liver disease and cholestasis: Novel advances in pathomechanisms-based prevention and treatment.
    Orso G; Mandato C; Veropalumbo C; Cecchi N; Garzi A; Vajro P
    Dig Liver Dis; 2016 Mar; 48(3):215-22. PubMed ID: 26698410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of cholecystokinin to prevent the development of parenteral nutrition-associated cholestasis.
    Teitelbaum DH; Han-Markey T; Drongowski RA; Coran AG; Bayar B; Geiger JD; Uitvlugt N; Schork MA
    JPEN J Parenter Enteral Nutr; 1997; 21(2):100-3. PubMed ID: 9084013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total parenteral nutrition-related liver disease.
    Sokol RJ
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1997; 38(6):418-28. PubMed ID: 9473812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of cholecystokinin-octapeptide to prevent TPN-associated gallstone disease.
    Tsai S; Strouse PJ; Drongowski RA; Islam S; Teitelbaum DH
    J Pediatr Surg; 2005 Jan; 40(1):263-7. PubMed ID: 15868595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholestasis affects enteral tolerance and prospective weight gain in the NICU.
    Niccum M; Khan MN; Middleton JP; Vergales BD; Syed S
    Clin Nutr ESPEN; 2019 Apr; 30():119-125. PubMed ID: 30904211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pruritus in pregnancy and obstetric cholestasis.
    Clark TJ; Dwarakanath L; Weaver JB
    Hosp Med; 1999 Apr; 60(4):254-60. PubMed ID: 10396430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total parenteral nutrition-associated cholestasis in surgical neonates may be reversed by intravenous cholecystokinin: a preliminary report.
    Rintala RJ; Lindahl H; Pohjavuori M
    J Pediatr Surg; 1995 Jun; 30(6):827-30. PubMed ID: 7666317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of ursodeoxycholic acid (UDCA) in the therapy of liver and biliary duct diseases in children.
    Lebensztejn DM
    Med Sci Monit; 2000; 6(3):632-6. PubMed ID: 11208384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parenteral nutrition-associated cholestasis in preterm neonates: evaluation of ursodeoxycholic acid treatment.
    Levine A; Maayan A; Shamir R; Dinari G; Sulkes J; Sirotta L
    J Pediatr Endocrinol Metab; 1999; 12(4):549-53. PubMed ID: 10417972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parenteral nutrition and hepatobiliary dysfunction.
    Farrell MK; Balistreri WF
    Clin Perinatol; 1986 Mar; 13(1):197-212. PubMed ID: 3082561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.